Acadian Asset Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Buy |
1,117,917
+311,976
| +39% | +$6.2M | 0.05% | 295 |
|
|
2025
Q1 | $13.6M | Buy |
805,941
+446,076
| +124% | +$7.53M | 0.04% | 276 |
|
|
2024
Q4 | $6.64M | Buy |
359,865
+59,287
| +20% | +$1.09M | 0.02% | 444 |
|
|
2024
Q3 | $6.53M | Buy |
300,578
+237,854
| +379% | +$5.16M | 0.02% | 427 |
|
|
2024
Q2 | $1.23M | Buy |
62,724
+53,680
| +594% | +$1.05M | ﹤0.01% | 927 |
|
|
2024
Q1 | $195K | Buy |
+9,044
| New | +$195K | ﹤0.01% | 1187 |
|
|
2023
Q2 | – | Sell |
-9,799
| Closed | -$305K | – | 1788 |
|
|
2023
Q1 | $305K | Hold |
9,799
| – | – | ﹤0.01% | 1166 |
|
|
2022
Q4 | $291K | Sell |
9,799
-11,036
| -53% | -$328K | ﹤0.01% | 1191 |
|
|
2022
Q3 | $793K | Buy |
20,835
+8,475
| +69% | +$323K | ﹤0.01% | 859 |
|
|
2022
Q2 | $675K | Sell |
12,360
-2,963
| -19% | -$162K | ﹤0.01% | 900 |
|
|
2022
Q1 | $955K | Hold |
15,323
| – | – | ﹤0.01% | 838 |
|
|
2021
Q4 | $1.54M | Sell |
15,323
-3,108
| -17% | -$313K | 0.01% | 724 |
|
|
2021
Q3 | $1.66M | Sell |
18,431
-20,755
| -53% | -$1.87M | 0.01% | 725 |
|
|
2021
Q2 | $3.61M | Buy |
+39,186
| New | +$3.61M | 0.01% | 552 |
|
|
2020
Q3 | – | Sell |
-147,717
| Closed | -$2.36M | – | 2233 |
|
|
2020
Q2 | $2.36M | Sell |
147,717
-70,389
| -32% | -$1.13M | 0.01% | 690 |
|
|
2020
Q1 | $2.35M | Buy |
218,106
+87,218
| +67% | +$939K | 0.01% | 560 |
|
|
2019
Q4 | $1.69M | Buy |
130,888
+110,207
| +533% | +$1.42M | 0.01% | 739 |
|
|
2019
Q3 | $214K | Buy |
+20,681
| New | +$214K | ﹤0.01% | 1306 |
|